View abstracts of studies supported by our research funding.

 
Select Filters
Apply Filters
Reset Filters

Restoring Excitation-Inhibition Balance in Alzheimer’s Disease Mouse Models

Moustafa Algamal, Ph.D.
Boston, MA - United States
2023

Undiagnosed Dementia in Hospitals: Prevalence, Risk Factors, and Outcomes

Márlon Aliberti, M.D., Ph.D.
Sao Paulo, Brazil
2023

Identifying Astrocyte-Mediated Vasomotion Underlying AD Pathogenesis

Xiaoqing Alice Zhou, Ph.D.
Boston, MA - United States
2023

Uncovering the Role of SORL1 as a Key Regulator of AD Endosomal Pathology

Brooke Alisen DeRosa, Ph.D.
Miami, FL - United States
2023

Influence of the Microenvironment on the Turnover of Fluid Biomarkers

Tatiana Alvarez Giovannucci, Ph.D.
London, United Kingdom
2023

Kv7 K+ channels, BACE1, APP, and Alzheimer's disease-related epilepsy

Fabio Antonio Borges Vigil, Ph.D.
San Antonio, TX - United States
2023

Multi-Omics Characterization of a Diverse Population in the South of Brazil

Marco Antônio De Bastiani, Ph.D.
PORTO ALEGRE, Brazil
2023

Targeted Network Attack in Assessing Brain Resilience

Georgette Argiris, Ph.D.
New York, NY - United States
2023

The Role of Astrocytic Tau Deposition onto Synaptic and Memory Dysfunction

Eleni-Kostania Argyrousi, Ph.D.
New York, NY - United States
2023

Assessing Meaningful Engagement in Advanced Dementia (MEAD)

Arlene Astell, Ph.D.
Toronto, Canada
2023

A CRISPR-Based Therapeutic for Alzheimer's disease

Brent Aulston, Ph.D.
La Jolla, CA - United States
2023

Underlying effects of ApoE variants on brain pericytes in CAA and AD

Praveen Bathini, Ph.D.
Boston, MA - United States
2023

AD Nanomedicines Targeting Vasculature Disfunction and Neuroinflammation

Giuseppe Battaglia, Ph.D.
Barcelona, Spain
2023

A Deep Learning Tool to Generalize Tau PET to Predict AD progression

Guilherme Bauer Negrini, Ph.D.
Pittsburgh, PA - United States
2023

Determining the Impact of Tau Aggregates on Neuron Loss with 2P Imaging

Rachel Bennett, Ph.D.
Boston, MA - United States
2023

Mechanisms of Complement Mediated Synaptic Removal Following Tauopathy

Matthew Benskey, Ph.D.
Grand Rapids, MI - United States
2023

Uncovering Mechanisms of Neuronal Hyperexcitability in Tauopathies

Steven Boggess, Ph.D.
San Francisco, CA - United States
2023

Blood Redox Biomarker for Dementia

Gregory Brewer, Ph.D.
Irvine, CA - United States
2023

Nanotau

Luc Buée, Ph.D.
Lille, France
2023

Uncovering Mechanisms of Axonal Pathology in Alzheimer's disease

Yifei Cai, Ph.D.
New Haven, CT - United States
2023

Continued Development of the Next Generation Environmental Assessment Tool

Margaret P Calkins. Ph.D.
Cleveland Heights, OH - United States
2023

Functional Analysis of the PSEN1 G206A Variant in Hispanics with Alzheimer's Disease

Katrina Celis, M.D.
Miami, FL - United States
2023

Mechanisms of Gamma-Secretase Modulators, Towards Rational Drug Design

Lucía Chávez-Gutiérrez, Ph.D.
Gent, Belgium
2023

MEG Predictors of Social Learning in Early AD and Behavioral-Variant FTD

Yu Chen, Ph.D., MPH
San Francisco, CA - United States
2023

Evaluation of Alzheimer's Endophenotype Networks Between Human and Mouse

Feixiong Cheng, Ph.D.
Cleveland, OH - United States
2023

Alzheimer’s Disease and Related Dementias in Gender Minority Adults

Ethan Collin Cicero, Ph.D.
Atlanta, GA - United States
2023

Can Subtyping of Alzheimer’s Heterogeneity Improve Clinical Trial Design?

Lyduine Collij, Ph.D.
Amsterdam, Netherlands
2023

ApoE Lipid Transport by ABCA7 Genetic Variants

Jamaine Davis, Ph.D.
Nashville, TN - United States
2023

Digital Platform for Precision Brain Health in the Bogalusa Heart Study

Ileana De Anda-Duran, M.D., MPH
New Orleans, LA - United States
2023

A Novel Item-Level Category Fluency Scoring to Detect AD at the MCI Stage

Matteo De Marco, Ph.D.
Uxbridge, United Kingdom
2023

1 2 3 4 5 6 7 8 9 10... >|